Publications by authors named "Alane Koki"

Claim this Profile
P
Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.
Jocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont, Valérie-Jeanne Bardou, Emmanuelle Charafe-Jauffret, Alane Koki

Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
Kai Wang, Khaldoun Tarakji, Zhongmin Zhou, Ming Zhang, Farhad Forudi, Alane T Koki

J Cardiovasc Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend disease.
Dave Cervi, Giannoula Klement, Diana Stempak, Sylvain Baruchel, Alane Koki

Clin Cancer Res· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression.
A-C Goulet, Janine G Einsphar, David S Alberts, Anthony Beas, Cynthia Burk, Alane Koki

Cancer Biol Ther· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of an ERBB2 gene expression signature in breast cancers.
François Bertucci, Nathalie Borie, Christophe Ginestier, Agnès Groulet, Emmanuelle Charafe-Jauffret, Alane Koki

Oncogene· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib.
David Cervi, Amandine H L Truong, Jane S Lee, Natasha Sukhai, You-Jun Li, Alane Koki

Oncogene· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Traci A Wilgus, Alane T Koki, Ben S Zweifel, Donna F Kusewitt, Patricia A Rubal

Mol Carcinog· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.
Traci A Wilgus, Alane T Koki, Ben S Zweifel, Patricia A Rubal, Tatiana M Oberyszyn

Mol Carcinog· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal effects of selective cyclooxygenase inhibition in experimental liver disease.
Marta López-Parra, Joan Clària, Anna Planagumà, Esther Titos, Jaime L Masferrer, Alane T Koki

Adv Exp Med Biol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase-2 in human pathological disease.
Alane Koki, Nasir K Khan, B Mark Woerner, A J Dannenberg, Lisa Olson

Adv Exp Med Biol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Medora M Hardy, Karen Seibert, Pamela T Manning, Mark G Currie, B Mark Woerner, Alane Koki

Arthritis Rheum· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib: a specific COX-2 inhibitor with anticancer properties.
Alane T Koki, Jaime L Masferrer

Cancer Control· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
Kathleen M Leahy, Richard L Ornberg, Yu Wang, Ben S Zweifel, Alane T Koki

Cancer Res· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
Marta López-Parra, Joan Clària, Anna Planagumà, Esther Titos, Jaime L Masferrer, Alane T Koki

Br J Pharmacol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis